SCHEMBL992411

SCHEMBL992411

C=C([SnH])OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13862155 0.74 ALDH1A1 (0.44)
SCHEMBL388497 0.74
SCHEMBL172783 0.71
Hydrochloric Acid SCHEMBL28031350 0.71 ALDH1A1 (0.42)
SCHEMBL1454569 0.71
SCHEMBL856276 0.71
SCHEMBL28270615 0.71 ALDH1A1 (0.47)
SCHEMBL3994371 0.70
SCHEMBL676464 0.69
SCHEMBL621665 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 764 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180037556-A1 COMPOUNDS AND METHODS FOR INDUCING BROWNING OF WHITE ADIPOSE TISSUE BEIJING ERAI THERAPEUTICS CO., LTD. (CN) 2018-02-08 US claimed
CN-116134035-B 3- (1H-imidazol-2-yl) -2,3,8 a-tetrahydroindol-5 (1H) -one derivatives useful as factor XIA inhibitors 詹森药业有限公司 2025-03-11 CN disclosed
CN-119528910-A Carboxyl condensed ring derivative regulator, preparation method and application thereof 江苏豪森药业集团有限公司 2025-02-28 CN disclosed
WO-2024149359-A1 PHENYL-SUBSTITUTED HETEROARYL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME, PREPARATION METHOD THEREFOR AND USE THEREOF 上海美悦生物科技发展有限公司 2024-07-18 WO disclosed
CN-118344325-A PI3K selective inhibitors 轩竹生物科技股份有限公司 2024-07-16 CN disclosed
CN-118355004-A Cyclopropyl- (heteroaryl) -substituted ethylsulfonyl-pyridine derivatives 勃林格殷格翰动物保健有限公司 2024-07-16 CN disclosed
CN-118344289-A Phenyl substituted heteroaryl compound, and pharmaceutical composition, preparation method and application thereof 上海美悦生物科技发展有限公司 2024-07-16 CN disclosed
CN-113195441-B Androgen receptor modulators and methods of use thereof 埃萨制药股份有限公司 2024-07-12 CN disclosed
WO-2024148150-A1 SUBSTITUTED SPIROCYCLIC-PYRROLOQUINAZOLINONES AND SPIROCYCLIC-PIPERIDINOQUINAZOLINONES Mirati Therapeutics, Inc. (US) 2024-07-11 WO disclosed
US-20240228482-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER HOTSPOT THERAPEUTICS, INC. 2024-07-11 US disclosed
EP-1215208-A2 4-Aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases Agouron Pharmaceuticals, Inc. (US) 2002-06-19 EP disclosed
WO-2002024682-A1 FARNESYL TRANSFERASE INHIBITING QUINOLINE AND QUINAZOLINE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2002-03-28 WO disclosed
EP-1056732-A2 4-AMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASES AGOURON PHARMACEUTICALS, INC. (US) 2000-12-06 EP disclosed
WO-1999021845-A2 4-AMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASES AGOURON PHARMACEUTICALS, INC. (US) 1999-05-06 WO disclosed
US-5354772-A Anticholesterol agents SANDOZ PHARM. CORP. (US) 1994-10-11 US disclosed
US-5272265-A 3-(substituted or unsubstituted) thiazolo-1-carba (1-dethia)cephems ELI LILLY AND COMPANY (US) 1993-12-21 US disclosed
US-5179088-A Administering bactericides ELI LILLY AND COMPANY (US) 1993-01-12 US disclosed
EP-0445925-A1 1-Carba(dethia)caphalosporin antibiotics ELI LILLY AND COMPANY (US) 1991-09-11 EP disclosed
US-4876280-A ANTICHOLESTEROL AGENTS; ATHEROSCLEROSIS; ANTILIPEMICS SANDOZ PHARM. CORP. (US) 1989-10-24 US disclosed
US-4739073-A ANTICHOLESTEROL AGENTS SANDOZ PHARMACEUTICALS CORP. (US) 1988-04-19 US disclosed